Hypaque Sodium 20%

   
Google
 
Web NewDrugInformation.com

Hypaque Sodium 20%


Drug - Hypaque Sodium 20%
The trade name of the product as shown on the labeling.

Dosage - SOLUTION; URETERAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Diatrizoate Sodium
Multiple ingredients are in alphabetical order.

Strength - 20%
The potency of the active ingredient(s), Diatrizoate Sodium. May repeat for multiple part products.

Applicant - GE HEALTHCARE
The firm name holding legal responsibility for Hypaque Sodium 20%. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 009561
The FDA assigned number to Hypaque Sodium 20%. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Hypaque Sodium 20%. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Hypaque Sodium 20% was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Hypaque Sodium 20%. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Hypaque Sodium 20% is in. Format is RX, OTC, DISCN.

Applicant Full Name - Ge Healthcare
The full name of the firm holding legal responsibility for the new application of Hypaque Sodium 20%.

Hypaque Sodium 20%